Analysis of data from HBV-HCC patients derived from TCGA also indicated that the expression of RSK2 and CREB was significantly higher in tumor tissues than in normal tissues, was positively correlated with tumor size, and that patients with increased expression of RSK2 and CREB had a shorter survival time and a worse prognosis. The gene discussed is CREB1; the disease is hepatocellular carcinoma.